PTC Therapeutics, Inc. (PTCT) was a big mover last session, as the company saw its shares surge a whopping 30.74% on the day. This tremendous rally can be attributable to solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $14.67 to $20.52 in the past one-month time frame, showed a pick-up yesterday at $20.03.
The company has seen no estimate revisions in the past 7 days, while its Zacks Consensus Estimate of a loss narrowed over the same time frame, suggesting that more solid trading could be ahead for PTC Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
PTC Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other attractive players in the healthcare industry include Myriad Genetics Inc. (MYGN) and ANI Pharmaceuticals, Inc. (ANIP), carrying a Zacks Rank #1 (Strong Buy) and Ariad Pharmaceuticals Inc. (ARIA) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment